We are international
Donate
• videos TEXT SIZE   

The 52nd Annual Meeting of the American Society of Hematology took place in Orlando, Florida December 4-7, 2010. The webcasts taped at the meeting are reports on the current status of some of the most interesting research in myeloma. Please be aware that at the time of posting, in some cases, the interviewees are reporting on interim data from incomplete clinical trials. Therefore not all the data presented are final results, and it is possible that results will be different when the data has matured with long-term follow-up. None of this research has yet been peer-reviewed and published in a medical journal.

Overviews
International Overviews
Revlimid
Thalomid
Velcade
New Agents
Transplant
Relapsed/Refractory
Myeloma Stem Cells
ASH 2010 IMF Satellite Symposium
MyrooM
Others
First Teleconference of 2011
Best of ASH – What Patients Need to Know
Brian G.M. Durie, MD
Chair, International Myeloma Foundation
Cedars-Sinai Outpatient Cancer Center
Los Angeles, CA
Dr. Barlogie's Overview of ASH 2010
Bart Barlogie, MD
University of Arkansas for Medical Sciences
Little Rock, Arkansas
USA

ASH 2010 Overview from Dr. Kenneth Anderson
Kenneth Anderson, MD
Dana-Farber Cancer Institute
Boston, Massachusetts
USA
ASH 2010 Overview from Dr. Vincent Rajkumar
S. Vincent Rajkumar
Mayo Clinic
Rochester, Minnesota
USA

Overview of ASH 2010 from Dr. Morie Gertz
Morie Gertz, MD
Mayo Clinic
Rochester, Minnesota
USA